The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure.

Harouki N, Nicol L, Remy-Jouet I, Henry JP, Dumesnil A, Lejeune A, Renet S, Golding F, Djerada Z, Wecker D, Bolduc V, Bouly M, Roussel J, Richard V, Mulder P.

Open source

DOI
10.1016/j.jacbts.2017.06.005
Published
2017-08-28
Container
JACC Basic Transl Sci
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jacbts.2017.06.005,
  title = {The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure.},
  author = {Harouki N and  Nicol L and  Remy-Jouet I and  Henry JP and  Dumesnil A and  Lejeune A and  Renet S and  Golding F and  Djerada Z and  Wecker D and  Bolduc V and  Bouly M and  Roussel J and  Richard V and  Mulder P.},
  year = {2017},
  journal = {JACC Basic Transl Sci},
  doi = {10.1016/j.jacbts.2017.06.005},
  url = {https://doi.org/10.1016/j.jacbts.2017.06.005}
}

RIS

TY  - JOUR
TI  - The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure.
AU  - Harouki N
AU  -  Nicol L
AU  -  Remy-Jouet I
AU  -  Henry JP
AU  -  Dumesnil A
AU  -  Lejeune A
AU  -  Renet S
AU  -  Golding F
AU  -  Djerada Z
AU  -  Wecker D
AU  -  Bolduc V
AU  -  Bouly M
AU  -  Roussel J
AU  -  Richard V
AU  -  Mulder P.
PY  - 2017
JO  - JACC Basic Transl Sci
DO  - 10.1016/j.jacbts.2017.06.005
UR  - https://doi.org/10.1016/j.jacbts.2017.06.005
ER  -

APA

N, H., L, N., I, R., JP, H., A, D., A, L., S, R., F, G., Z, D., D, W., V, B., M, B., J, R., V, R., & P., M. (2017). The IL-1β Antibody Gevokizumab Limits Cardiac Remodeling and Coronary Dysfunction in Rats With Heart Failure.. JACC Basic Transl Sci. https://doi.org/10.1016/j.jacbts.2017.06.005

Source records